IP Library Assignment 040371/0901
Patent Assignment
Reel/Frame 040371/0901

Assignment of Assignor's Interest

Recorded: 2016-11-18 Pages: 6
Assignors
QUINN, JOHN FREDERICK
Executed: 2013-07-09
DUFFY, BRYAN CORDELL
Executed: 2013-07-12
LIU, SHUANG
Executed: 2013-07-12
WANG, RUIFANG
Executed: 2013-07-12
JIANG, MAY XIAOWU
Executed: 2013-07-12
MARTIN, GREGORY SCOTT
Executed: 2013-07-12
WAGNER, GREGORY STEVEN
Executed: 2013-07-26
YOUNG, PETER RONALD
Executed: 2013-07-10
Assignee
RVX THERAPEUTICS INC.
279 MIDPARK WAY SE, CALGARY, AB, T2X 1M2, CANADA
Covered Property (1)
Novel Bicyclic Bromodomain Inhibitors
Patent: 9,663,520 →
Application: 14/977,508 →
Publication: US 2016/0159801
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
General Conveyance and Assumption Agreement Nov 18, 2016
From: RVX THERAPEUTICS INC.
To: ZENITH EPIGENETICS CORP.
Reel/Frame 040647/0908 →
Assignment of Assignor's Interest Nov 18, 2016
From: QUINN, JOHN FREDERICK; WAGNER, GREGORY STEVEN; DUFFY, BRYAN CORDELL; LIU, SHUANG
To: ZENITH EPIGENETICS CORP.
Reel/Frame 040652/0495 →
Change of Name Dec 21, 2016
From: ZENITH EPIGENETICS CORP.
To: ZENITH CAPITAL CORP.
Reel/Frame 041120/0548 →
Assignment of Assignor's Interest Dec 23, 2016
From: ZENITH CAPITAL CORP.
To: ZENITH EPIGENETICS LTD.
Reel/Frame 041182/0891 →